World Wires · story 22632 · official · 1 source(s)

SCHEDULE 13D/A: Roivant Sciences Ltd. discloses a stake in Arbutus Biopharma Corp

Filed: 2026-10-05 AccNo: 0001140361-26-038693 Size: 21 KB

Open in the desk

Coverage

• SCHEDULE 13D/A: Roivant Sciences Ltd. discloses a stake in Arbutus Biopharma Corp SEC EDGAR: Schedule 13D stakes · tier A · clear net · 2026-10-06 01:02 UTC

What this site indexes